EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieOpen Access · CC BY 4.0

Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age

Maaike van der Staak iD, Hinke I Ten Hulscher, Alina M Nicolaie iD, Gaby P Smits, Rik L de Swart iD, Jelle de Wit iD, Nynke Y Rots iD, Robert S van Binnendijk iD

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciae537 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Maaike van der Staak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, Measles, Measles virus. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Ministry of Health, Welfare, and Sport.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Measles is a highly contagious disease, presenting a significant risk for unvaccinated infants and adults. Measles vaccination under the age of 12 months provides early protection but has also been associated with blunting of antibody responses to subsequent measles vaccinations and assumed to have lower vaccine effectiveness.

Methods

Our study included children who received an early measles, mumps, and rubella (MMR) vaccination between 6 and 12 months of age (n = 79, given in addition to the regular MMR vaccination schedule at 14 months and 9 years) and a group without additional early vaccination (n = 44). We evaluated measles virus (MeV)–specific neutralizing antibodies before vaccination at 14 months and up to 6 years thereafter using a plaque reduction neutralization test according to the standard set by the World Health Organization.

Results

We found a significant association between age of first MMR and MeV-specific neutralizing antibody levels later in life. Although most children who received early vaccination seroconverted after the first dose, children vaccinated before 8.5 months of age exhibited a markedly faster antibody decay and lost their protective neutralizing antibody levels over 6 years.

Conclusions

Routine vaccination of infants under 8.5 months of age may lead to blunted MeV-specific antibody responses to subsequent MMR vaccination. Early MMR vaccination should only be considered during measles outbreaks or in other situations of increased risk of MeV infection. Clinical Trials Registration. EudraCT 2013-003078-28.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingAntibodies, ViralMeaslesMeasles virusMeasles-Mumps-Rubella VaccineChildChild, PreschoolFemaleHumansInfantMaleImmunization ScheduleNeutralization TestsVaccination

Stichwörter der Autor:innen

MMR vaccineearly infant vaccinationimmunitylong-term immune protectionmeasles

Substanzen

Antibodies, NeutralizingAntibodies, ViralMeasles-Mumps-Rubella Vaccine

Autor:innen und Institutionen

  • Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.

ORCID-Profile: Maaike van der Staak, Alina M Nicolaie, Rik L de Swart, Jelle de Wit, Nynke Y Rots, Robert S van Binnendijk

Förderung

  • Dutch Ministry of Health, Welfare, and Sport

Zitieren

APA

van der Staak, M., Ten Hulscher, H. I., Nicolaie, A. M., Smits, G. P., de Swart, R. L., de Wit, J., Rots, N. Y., & van Binnendijk, R. S. (2025). Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae537

Vancouver

van der Staak M, Ten Hulscher HI, Nicolaie AM, Smits GP, de Swart RL, de Wit J, et al. Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae537

BibTeX
@article{vanderStaak2025,
  author = {van der Staak, Maaike and Ten Hulscher, Hinke I and Nicolaie, Alina M and Smits, Gaby P and de Swart, Rik L and de Wit, Jelle and Rots, Nynke Y and van Binnendijk, Robert S},
  title = {Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciae537}
}
Kostenlos starten →